Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Strangely quiet
View:
Post by Joemare on Oct 25, 2022 9:58am

Strangely quiet

Can't put my fingers on it.
Last couple of weeks of trading, yesterday was also bizarre.  Again, the conference call......

What do they have to 'hide'?
a) Good results are due any moment?
b) Deal of some sort?
c) Clinical trial delays
d) Protocol amendment to fast-track patient accrual?
e) Departure of an executive?

What is it that they can't get ahead of the game?
Comment by Lee430 on Oct 25, 2022 10:33am
Maybe we are on the cusp of 2 responders for a go signal with Break Through Therapy designation!
Comment by SABBOBCAT on Oct 25, 2022 11:20am
Or perhaps not... that would constitute material information, no? 
Comment by Lee430 on Oct 25, 2022 11:25am
Oh well, so much for hanging out in my happy spot ;-(
Comment by Biobob on Oct 25, 2022 11:42am
Lets all be polically correct and express our joy in light of the coming news. Let us not disturb the good spirit with our negative opinions.  Let us be jolly and woke while we wait some more.  May the woke be with you my friends.
Comment by SPCEO1 on Oct 25, 2022 12:49pm
I imagine the quiet might be broken by a press release on the info they will be presenting at the cancer conference in Europe.  Also, I have to believe Truist will be out with a research report at some point soon given they were taking TH to see some of their clients. Since they helped TH with the debt deal with Marathon and made a nice fee for that, itmakes sense they would pick up coverage ...more  
Comment by Joemare on Oct 25, 2022 1:08pm
I'm hopeful Truist will issue something of quality which would include their preliminary analysis of the oncology program. That can help get others interested and would likely be something of our interest too.  The preclinical stuff is baked in right now.  What triggers biotech share increase is an oral presentation of clinical data, or late-breaking abstract presentation...that ...more  
Comment by palinc2000 on Oct 25, 2022 1:15pm
Apart from the divorce settlement maybe another reason is that some small retail investors were faced with the unfortunate combination of fast women and slow horses!!!! Seriously commenting on the daily  price variations of the SP on relatively small volume is not constructive and adds nothing
Comment by canasol46 on Oct 25, 2022 12:36pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities